Leadership at Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center is led by a director, a deputy director, and team of associate center directors representing all aspects of the center. A Cancer Clinical Enterprise Committee oversees strategy and decision-making for the clinical operations of the center. Vanderbilt-Ingram Cancer Center is also guided by a volunteer community Board of Overseers and external scientific advisory board.
Executive Leadership Team
- Jennifer A. Pietenpol, Ph.D.
Director, Vanderbilt-Ingram Cancer Center - Theresa M. Keske Sberna, M.P.H.
Chief Business Officer; Deputy Director for Strategy and Analytics - W. Kimryn (Kim) Rathmell, M.D., Ph.D.
Deputy Director for Research Integration and Career Development
Associate Directors
- Jordan D. Berlin, M.D.
Associate Director for Clinical Research - David K. Cortez, Ph.D.
Associate Director for Basic Science Research - Debra L. Friedman, M.D.
Associate Director for Community Science and Health Outcomes - Catherine Gregor, M.B.A., CCRC, CCRP
Director, Clinical Research Administration - Scott Hiebert, Ph.D.
Associate Director for Shared Resources - Beth Jones, M.A.
- Executive Director of Development
- Michelle Martin-Pozo, Ph.D.
Administrative Director for Partnerships, Education and Operations - Tuya Pal, M.D.
Associate Director for Cancer Health Disparities - Ben Ho Park, M.D., Ph.D.
Associate Director of Translational Research - Xiao-Ou Shu, M.D., Ph.D.
- Associate Director for Global Health
- Julie C. Schaum, M.S.
Associate Director for Research Administration - Yu Shyr, Ph.D.
Associate Director for Quantitative Sciences - Anne Washburn, M.P.H.
Administrative Director for Community Relations and Affiliations - Wei Zheng, M.D., Ph.D., M.P.H.
Associate Director for Population-Based Research
Research Program Leaders
Breast Cancer Research Program
Cancer Epidemiology Research Program
Cancer Health Outcomes and Control Research Program
Gastrointestinal Cancer Research Program
Genome Maintenance Research Program
Host-Tumor Interactions Research Program
Signal Transduction and Chemical Biology Research Program
Translational Research and Interventional Oncology Research Program
Other Key Leaders
- Georgia Wiesner, M.D., M.S.
Director, Clinical and Translational Hereditary Cancer Program
Executive Committee
- Jennifer A. Pietenpol, Ph.D., Chair
- Ronald Alvarez, M.D., M.B.A.
- Dan Beauchamp, M.D.
- Jordan Berlin, M.D.
- Sam Chang, M.D., M.B.A.
- David K. Cortez, Ph.D.
- Nancy Davis, M.D.
- Roland Eavey, M.D.
- Debra L. Friedman, M.D.
- Laura Goff, M.D.
- Catherine Gregor, M.B.A., CCRC, CCRP
- Scott Hiebert, Ph.D.
- Kamran Idrees, M.D., M.S.C.I., M.M.H.C., FACS
- Beth Jones, M.A.
- Michelle Martin-Pozo, Ph.D.
- Tuya Pal, M.D.
- Ben Ho Park, M.D., Ph.D.
- David Penson, M.D., M.P.H., MMHC
- W. Kimryn (Kim) Rathmell, M.D., Ph.D.
- Brian Rini, M.D.
- Theresa M. Keske Sberna, M.P.H.
- Julie C. Schaum, M.S.
- Xiao-Ou Shu, M.D., Ph.D.
- Yu Shyr, Ph.D.
- Anne Washburn, M.P.H.
- Wei Zheng, M.D., Ph.D, M.P.H.
- Mary M. Zutter, M.D.
